AI and blood tests join forces to crack the code of hormone disorders
NCT ID NCT07253454
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will use machine learning and metabolomics (detailed analysis of blood chemicals) to improve diagnosis of hyperandrogenism, a condition causing excess male hormones in women. Researchers will analyze data from 800 women aged 16-45 to better distinguish between common causes like PCOS and rarer genetic conditions. The goal is to create tools that lead to faster, more accurate diagnoses and better management of related health issues like infertility.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to faster, more accurate diagnosis of the cause of hyperandrogenism, helping tailor treatment and reduce infertility.
- What could go wrong
- This is an observational study using existing data, not a treatment trial. The machine learning models may not prove reliable enough for routine clinical use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERANDROGENISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.